News
![Form 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
![Rights and Issues Investment Trust PLC: Net Asset Value(s)](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
![Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
![Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
![Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
![Form 8.3 - The Vanguard Group, Inc.: Playtech plc](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
![Form 8.3 - The Vanguard Group, Inc.: National Express Group plc](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
![Form 8.3 - The Vanguard Group, Inc.: GCP Student Living plc](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Form 8.3 - The Vanguard Group, Inc.: GCP Student Living plc
Form 8.3 - The Vanguard Group, Inc.: GCP Student Living plc
![Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
![DGAP-News: Dermapharm Holding SE acquires C³-Group and expands its activities in the cannabis market](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
DGAP-News: Dermapharm Holding SE acquires C³-Group and expands its activities in the cannabis market
DGAP-News: Dermapharm Holding SE acquires C³-Group and expands its activities in the cannabis market
![DGAP-Adhoc: Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
DGAP-Adhoc: Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH
DGAP-Adhoc: Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH
![Form 8 (DD) - Kevin Parry PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Form 8 (DD) - Kevin Parry PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT
Form 8 (DD) - Kevin Parry PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT
![Director/PDMR Shareholding](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Director/PDMR Shareholding
Director/PDMR Shareholding
![Hardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mike Foster on Palace Capital (PCA) | Interim results - ammunition for major dividend rises](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Hardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mike Foster on Palace Capital (PCA) | Interim results - ammunition for major dividend rises
Hardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mike Foster on Palace Capital (PCA) | Interim results - ammunition for major dividend rises
![Manz AG: Order from Germany's leading toy manufacturer for digital printing on products and packaging](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Manz AG: Order from Germany's leading toy manufacturer for digital printing on products and packaging
Manz AG: Order from Germany's leading toy manufacturer for digital printing on products and packaging
![Arix Bioscience PLC: Depixus raises €30.6M (£26.1 million) in Series A Financing](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Arix Bioscience PLC: Depixus raises €30.6M (£26.1 million) in Series A Financing
Arix Bioscience PLC: Depixus raises €30.6M (£26.1 million) in Series A Financing
![DGAP-News: XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
DGAP-News: XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips
DGAP-News: XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips
![ROSNEFT OIL COMPANY: Rosneft Upgraded its Position in S&P Global's International ESG Rating](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
ROSNEFT OIL COMPANY: Rosneft Upgraded its Position in S&P Global's International ESG Rating
ROSNEFT OIL COMPANY: Rosneft Upgraded its Position in S&P Global's International ESG Rating
![Magnit and Delivery Club launch thirty-minute express grocery delivery](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Magnit and Delivery Club launch thirty-minute express grocery delivery
Magnit and Delivery Club launch thirty-minute express grocery delivery
![DGAP-News: artnet AG: Artnet Announces Launch of ArtNFT: Beginnings, the inaugural sale on its Cryptonative NFT Platform](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
DGAP-News: artnet AG: Artnet Announces Launch of ArtNFT: Beginnings, the inaugural sale on its Cryptonative NFT Platform
DGAP-News: artnet AG: Artnet Announces Launch of ArtNFT: Beginnings, the inaugural sale on its Cryptonative NFT Platform
![Travis Perkins: Transaction in Own Shares](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
![DGAP-News: SMT Scharf AG: Core shareholders consider divesting their interest in SMT Scharf AG](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
DGAP-News: SMT Scharf AG: Core shareholders consider divesting their interest in SMT Scharf AG
DGAP-News: SMT Scharf AG: Core shareholders consider divesting their interest in SMT Scharf AG
![EQS-Adhoc: Polyphor and EnBiotix announce dosing of first patient in a first-in-human clinical trial of inhaled murepavadin](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
EQS-Adhoc: Polyphor and EnBiotix announce dosing of first patient in a first-in-human clinical trial of inhaled murepavadin
EQS-Adhoc: Polyphor and EnBiotix announce dosing of first patient in a first-in-human clinical trial of inhaled murepavadin
![EQS-News: Sonova nominates Julie Tay for election as a new member of
the Board of Directors](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
EQS-News: Sonova nominates Julie Tay for election as a new member of the Board of Directors
EQS-News: Sonova nominates Julie Tay for election as a new member of
the Board of Directors
![EQS-Adhoc: Orascom Development Holding AG announces Chairman's Succession Plan.](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
EQS-Adhoc: Orascom Development Holding AG announces Chairman's Succession Plan.
EQS-Adhoc: Orascom Development Holding AG announces Chairman's Succession Plan.